Pfizer (PFE) is in focus as the pharmaceutical giant launches its own telehealth and prescription platforms, marking its foray into the direct-to-consumer market. This comes after competitor Eli Lilly (LLY) made a similar move back in January.

Yahoo Finance senior health reporter Anjalee Khemlani breaks down the details, discussing the partnerships the company will utilize and how it will improve consumer access to prescription drugs and vaccines.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

This post was written by Angel Smith